Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › OPA1 antisense oligomers for treatment of conditions and diseases

OPA1 antisense oligomers for treatment of conditions and diseases

US Patent 11814622 · Granted Nov 14, 2023

Estimated economic value: $3,531,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

OPA1 antisense oligomers for treatment of conditions and diseases2025
OPA1 antisense oligomers for treatment of conditions and diseases2025
OPA1 antisense oligomers for treatment of conditions and diseases2025
Methods and compositions for treatment of cholesteryl ester storage disease2024
Antisense oligomers for treatment of conditions and diseases2024
Reducing nonsense-mediated MRNA decay2022
Antisense oligomers and uses thereof2021
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and2021
Antisense oligomers for treatment of conditions and diseases2021
Targeted augmentation of nuclear gene output2020
Antisense oligomers for treatment of conditions and diseases2020
Reducing nonsense-mediated mRNA decay2020